Found: 6
Select item for more details and to access through your institution.
Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 6, p. 1989, doi. 10.1007/s00277-023-05603-w
- By:
- Publication type:
- Article
Single‐cell immune profiling reveals markers of emergency myelopoiesis that distinguish severe from mild respiratory syncytial virus disease in infants.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 12, p. 1, doi. 10.1002/ctm2.1507
- By:
- Publication type:
- Article
High‐Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action.
- Published in:
- Cytometry. Part A, 2019, v. 95, n. 3, p. 279, doi. 10.1002/cyto.a.23693
- By:
- Publication type:
- Article
Exploring Glucocorticoid Receptor Agonists Mechanism of Action Through Mass Cytometry and Radial Visualizations.
- Published in:
- Cytometry. Part B, 2017, v. 92, n. 1, p. 42, doi. 10.1002/cyto.b.21499
- By:
- Publication type:
- Article
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 3, p. 255, doi. 10.1038/nbt.1759
- By:
- Publication type:
- Article
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors.
- Published in:
- Nature Biotechnology, 2007, v. 25, n. 9, p. 1035, doi. 10.1038/nbt1328
- By:
- Publication type:
- Article